UNSPSC 51391900: Sympathomimetic or adrenergic azepines

Sympathomimetic or adrenergic drugs made from seven-membered heterocyclic rings containing a nitrogen atom.

UNSPSC 51391900 Sympathomimetic or adrenergic azepines is a Class code that encompasses pharmaceutical procurement by state and local health agencies, including naloxone and related emergency medical supplies, along with pharmacy benefit management systems and direct-to-manufacturer prescription programs. State and local issuing bodies soliciting under this code include county health departments and state health and human services commissions. Seminole County, Florida and the Texas Health and Human Services Commission represent the primary recent buyers. The scope of work spans both physical pharmaceutical products—naloxone units and drug deactivation systems for community health initiatives—and procurement infrastructure for pharmacy benefit programs, including direct contracting arrangements between state agencies and pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels.

Recent activity concentrates in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, and requiring quarterly deliveries to the county's community health building with vendor-paid shipping. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would establish direct relationships between the state's pharmacy benefit program and manufacturers to improve fulfillment efficiency and cost management, with responses due April 3, 2026. The Texas RFI represents preliminary market intelligence gathering rather than a formal competitive solicitation and will inform the state's future RFP strategy for pharmacy benefit contracting.